ABI;pval_01;BH_adj_pval;dm;low;high;Genes..0...uknown;David Input;Gene name;Notes;203079;1e-04;0,0083;1,40;9,68;11,08;0;;;;115895;0,0041;0,0092;0,75;9,42;10,17;0;;;;199376;0,0051;0,0092;0,73;9,96;10,69;0;;;;125726;0,0050;0,0092;-0,70;14,27;13,57;0;;;;108672;0,0064;0,0093;-0,69;16,59;15,90;0;;;;141631;0,0065;0,0093;-0,66;13,90;13,24;0;;;;103239;0,0023;0,0092;-0,65;10,19;9,54;0;;;;356563;0,0008;0,0083;0,65;9,86;10,51;0;;;;703936;0,0043;0,0092;-0,65;10,86;10,21;0;;;;180287;0,0075;0,0096;-0,63;9,79;9,16;0;;;;231712;0,0029;0,0092;0,60;9,27;9,87;0;;;;170508;0,0059;0,0093;-0,56;10,08;9,52;0;;;;173479;0,0044;0,0092;0,55;9,22;9,77;0;;;;166535;0,0048;0,0092;-0,53;10,00;9,46;0;;;;237087;0,0057;0,0093;0,51;9,96;10,47;0;;;;234861;0,0048;0,0092;0,51;9,18;9,69;0;;;;163227;0,0081;0,0097;0,51;16,13;16,63;0;;;;139881;0,0024;0,0092;0,50;13,57;14,08;0;;;;125668;0,0030;0,0092;-0,49;10,06;9,57;0;;;;132368;0,0028;0,0092;-0,49;10,26;9,77;0;;;;202014;0,0067;0,0094;-0,49;10,81;10,32;0;;;;125537;0,0084;0,0097;-0,49;10,53;10,05;0;;;;128179;0,0064;0,0093;0,47;9,46;9,93;0;;;;177660;0,0071;0,0095;0,47;9,37;9,84;0;;;;240288;0,0021;0,0092;0,47;9,47;9,94;0;;;;143456;0,0065;0,0093;-0,47;10,82;10,35;0;;;;198356;0,0068;0,0095;0,47;11,41;11,87;0;;;;545088;0,0073;0,0095;0,46;9,14;9,61;0;;;;114538;0,0050;0,0092;0,46;9,61;10,07;0;;;;174536;0,0006;0,0083;0,45;14,04;14,50;0;;;;113154;0,0073;0,0095;-0,45;10,68;10,23;0;;;;10409147;0,0086;0,0097;0,44;9,37;9,81;0;;;;113939;0,0022;0,0092;-0,44;12,45;12,01;0;;;;132702;0,0010;0,0083;0,44;13,84;14,28;0;;;;145205;0,0076;0,0096;-0,44;10,25;9,81;0;;;;156066;0,0010;0,0083;-0,43;13,79;13,36;0;;;;234019;0,0096;0,0100;-0,43;10,64;10,21;0;;;;353232;0,0012;0,0083;0,42;9,41;9,83;0;;;;193647;0,0018;0,0087;0,42;14,63;15,05;0;;;;220479;0,0028;0,0092;-0,42;12,08;11,66;0;;;;216824;0,0098;0,0100;-0,40;11,79;11,38;0;;;;151000;0,0013;0,0083;0,40;17,80;18,20;0;;;;120738;0,0088;0,0097;0,40;9,24;9,64;0;;;;207587;0,0029;0,0092;0,40;13,67;14,06;0;;;;151049;0,0035;0,0092;-0,39;10,57;10,18;0;;;;162353;0,0035;0,0092;0,39;11,22;11,61;0;;;;170428;0,0005;0,0083;-0,39;11,82;11,43;0;;;;152640;0,0024;0,0092;0,38;18,19;18,57;0;;;;709104;0,0099;0,0100;0,38;9,40;9,78;0;;;;229372;0,0020;0,0088;0,38;10,00;10,38;0;;;;119787;0,0089;0,0097;0,38;11,19;11,57;0;;;;124424;0,0099;0,0100;0,38;12,97;13,35;0;;;;103870;0,0012;0,0083;0,37;10,91;11,28;0;;;;143814;0,0049;0,0092;0,37;15,16;15,53;0;;;;233719;0,0009;0,0083;-0,37;14,15;13,78;0;;;;165355;0,0037;0,0092;-0,36;11,60;11,24;0;;;;140620;0,0038;0,0092;0,36;13,87;14,23;0;;;;190550;0,0082;0,0097;-0,36;11,48;11,12;0;;;;172523;0,0087;0,0097;-0,35;13,03;12,68;0;;;;212680;0,0025;0,0092;0,35;14,34;14,69;0;;;;128088;0,0100;0,0100;0,35;13,37;13,72;0;;;;491183;0,0060;0,0093;0,35;9,56;9,91;0;;;;111032;0,0059;0,0093;0,35;12,82;13,16;0;;;;182618;0,0050;0,0092;-0,35;12,33;11,99;0;;;;232694;0,0004;0,0083;-0,34;17,58;17,24;0;;;;116454;0,0031;0,0092;-0,34;13,24;12,90;0;;;;204681;0,0076;0,0096;0,34;11,46;11,79;0;;;;111497;0,0011;0,0083;-0,34;15,05;14,71;0;;;;200967;0,0040;0,0092;0,34;15,41;15,75;0;;;;187317;0,0031;0,0092;0,34;17,09;17,43;0;;;;167512;0,0035;0,0092;0,33;13,97;14,30;0;;;;183195;0,0059;0,0093;0,33;9,98;10,31;0;;;;129133;0,0062;0,0093;0,33;12,12;12,45;0;;;;236579;0,0065;0,0093;0,33;16,90;17,23;0;;;;200105;0,0081;0,0097;-0,33;10,68;10,35;0;;;;101447;0,0067;0,0094;0,32;11,54;11,87;0;;;;149052;0,0039;0,0092;0,32;10,36;10,68;0;;;;229497;0,0045;0,0092;0,32;12,80;13,11;0;;;;135048;0,0061;0,0093;-0,32;17,31;16,99;0;;;;189717;0,0041;0,0092;-0,31;12,60;12,29;0;;;;134997;0,0071;0,0095;0,31;10,10;10,41;0;;;;191369;0,0034;0,0092;-0,31;12,62;12,31;0;;;;541843;0,0062;0,0093;0,30;11,76;12,06;0;;;;177879;0,0030;0,0092;0,30;13,63;13,92;0;;;;425760;0,0068;0,0095;-0,30;12,14;11,85;0;;;;148475;0,0034;0,0092;-0,30;11,90;11,60;0;;;;210449;0,0034;0,0092;-0,29;13,85;13,56;0;;;;205314;0,0039;0,0092;0,29;10,25;10,54;0;;;;161840;0,0074;0,0095;-0,29;10,08;9,79;0;;;;102338;0,0033;0,0092;-0,29;13,82;13,54;0;;;;226801;0,0056;0,0093;-0,28;11,57;11,28;0;;;;232342;0,0013;0,0083;-0,28;18,19;17,91;0;;;;195142;0,0063;0,0093;0,28;10,51;10,79;0;;;;145286;0,0048;0,0092;-0,28;13,53;13,25;0;;;;234565;0,0081;0,0097;0,27;12,79;13,06;0;;;;142469;0,0033;0,0092;0,27;10,84;11,11;0;;;;220077;0,0063;0,0093;-0,27;17,75;17,48;0;;;;104697;0,0060;0,0093;-0,27;13,36;13,10;0;;;;148728;0,0011;0,0083;0,26;10,39;10,65;0;;;;234408;0,0060;0,0093;-0,26;13,34;13,07;0;;;;233504;0,0077;0,0096;-0,26;14,99;14,73;0;;;;118791;0,0064;0,0093;-0,25;12,56;12,31;0;;;;131064;0,0087;0,0097;-0,25;14,67;14,42;0;;;;236949;0,0083;0,0097;-0,24;13,54;13,30;0;;;;109048;0,0045;0,0092;-0,24;18,97;18,73;0;;;;130918;0,0063;0,0093;-0,23;12,49;12,26;0;;;;155996;0,0078;0,0097;-0,20;12,41;12,22;0;;;;177196;0,0002;0,0083;-0,45;10,64;10,19;ACOT1;ACOT1;acyl-CoA thioesterase 1;fa;126241;0,0051;0,0092;-0,34;17,45;17,11;ADIPOR1;ADIPOR1;adiponectin receptor 1;fa, d;224660;0,0015;0,0083;-0,54;9,96;9,42;AGGF1;AGGF1;angiogenic factor with G patch and FHA domains 1;cc;112571;0,0060;0,0093;0,48;11,17;11,65;AMPD2;AMPD2;adenosine monophosphate deaminase 2 (isoform L);;195478;0,0028;0,0092;-0,38;10,03;9,65;ANAPC1;ANAPC1;"anaphase promoting complex subunit 1; similar to anaphase promoting complex subunit 1";cc;102558;0,0037;0,0092;0,64;11,69;12,34;ANPEP;ANPEP;alanyl (membrane) aminopeptidase;i, cc,;cd13. renin-angio170701;0,0099;0,0100;0,41;10,17;10,58;ARSA;ARSA;arylsulfatase A;;166802;0,0026;0,0092;-0,24;11,83;11,58;ASNS;ASNS;asparagine synthetase;er, cc;Er strss, nutrients, upreg byER stress. Chop, c/ebp, at4 187978;0,0092;0,0098;0,44;11,01;11,45;ASPRV1;ASPRV1;aspartic peptidase, retroviral-like 1;;114409;0,0015;0,0083;-0,24;12,17;11,94;ATCAY;ATCAY;ataxia, cerebellar, Cayman type;;151844;0,0056;0,0093;0,29;13,84;14,13;ATP6V1B2;ATP6V1B2;ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2;;150758;0,0012;0,0083;0,48;10,60;11,08;B9D2;B9D2;B9 protein domain 2;;105279;0,0055;0,0093;0,37;9,77;10,15;BAGE3;BAGE3;"B melanoma antigen family, member 2; B melanoma antigen family, member 3; B melanoma antigen family, member 4; B melanoma antigen family, member 5";;Not expressed in normal tissues, is candiate tumor antigen198318;0,0043;0,0092;0,38;17,76;18,14;BASP1;BASP1;brain abundant, membrane attached signal protein 1;;103435;0,0072;0,0095;-0,29;10,49;10,20;C16orf88;C16orf88;chromosome 16 open reading frame 88;;146237;0,0077;0,0096;-0,25;10,95;10,71;C1orf102;;;;222639;0,0068;0,0095;0,58;9,40;9,98;C20orf200;C20orf200;chromosome 20 open reading frame 200;;115087;0,0050;0,0092;0,27;11,53;11,80;C21orf7;C21orf7;chromosome 21 open reading frame 7;;116986;0,0015;0,0083;-0,34;11,55;11,22;C2orf44;C2orf44;chromosome 2 open reading frame 44;;106486;0,0019;0,0088;0,35;11,26;11,60;C2orf68;C2orf68;chromosome 2 open reading frame 68;;196942;0,0063;0,0093;0,56;12,27;12,83;CA4;CA4;carbonic anhydrase IV;;149818;0,0018;0,0087;-0,33;10,70;10,37;CACNG8;CACNG8;calcium channel, voltage-dependent, gamma subunit 8;ca;127383;0,0006;0,0083;0,41;13,15;13,56;CASS4;CASS4;Cas scaffolding protein family member 4;cc? i?;108110;0,0002;0,0083;0,42;9,59;10,01;CCKAR;CCKAR;cholecystokinin A receptor;;feeding, dopamine, hallucination, panic, etc167437;0,0028;0,0092;0,49;9,27;9,76;CCL7;CCL7;chemokine (C-C motif) ligand 7;i;migration156018;0,0031;0,0092;-0,38;11,07;10,69;CCNG1;CCNG1;cyclin G1;cc;growth inhibition180503;0,0032;0,0092;-0,52;13,05;12,53;CCR5;CCR5;chemokine (C-C motif) receptor 5;d, i, fa;masse! Cholesterol… insuline166481;0,0038;0,0092;0,36;12,37;12,73;CD2BP2;CD2BP2;CD2 (cytoplasmic tail) binding protein 2;;114892;0,0058;0,0093;0,28;13,31;13,59;CDAN1;CDAN1;congenital dyserythropoietic anemia, type I;;104276;0,0086;0,0097;0,49;14,38;14,87;CLEC4E;CLEC4E;C-type lectin domain family 4, member E;i;cebpb215843;0,0075;0,0096;0,37;11,29;11,66;CLN6;CLN6;ceroid-lipofuscinosis, neuronal 6, late infantile, variant;;er, cholesterol185846;0,0002;0,0083;0,43;10,74;11,17;CORO1B;CORO1B;coronin, actin binding protein, 1B;;migration100989;0,0009;0,0083;1,36;9,82;11,17;CPA3;CPA3;carboxypeptidase A3 (mast cell);;renin-angio181617;0,0076;0,0096;-0,25;12,26;12,01;CREBL2;CREBL2;cAMP responsive element binding protein-like 2;cc;tumor suppressor?196102;0,0011;0,0083;0,42;10,50;10,92;CRK;CRK;v-crk sarcoma virus CT10 oncogene homolog (avian);carc,;cell migration,208454;0,0004;0,0083;-0,54;11,16;10,63;CRTAM;CRTAM;cytotoxic and regulatory T cell molecule;i;pro-inflam188846;0,0029;0,0092;0,29;14,20;14,50;CTBS;CTBS;chitobiase, di-N-acetyl-;;142147;0,0081;0,0097;-0,34;10,13;9,79;CYP4F22;CYP4F22;cytochrome P450, family 4, subfamily F, polypeptide 22;;114009;0,0055;0,0093;-0,32;12,88;12,55;DCP1B;DCP1B;DCP1 decapping enzyme homolog B (S. cerevisiae);;RNA nedbryting211972;0,0031;0,0092;-0,24;11,92;11,68;DDX18;DDX18;DEAD (Asp-Glu-Ala-Asp) box polypeptide 18;cc;helicase. Overexpr in tumor cells167436;0,0092;0,0098;-0,35;10,25;9,91;DDX20;DDX20;DEAD (Asp-Glu-Ala-Asp) box polypeptide 20;;spliceosome, helicase177477;0,0097;0,0100;0,43;10,77;11,20;DDX55;DDX55;DEAD (Asp-Glu-Ala-Asp) box polypeptide 55;;helicase204688;0,0077;0,0096;0,34;14,23;14,57;DGAT2;DGAT2;diacylglycerol O-acyltransferase homolog 2 (mouse);fa, d, ;decr expr in psoriactic skin, c/ebpb, adipiogenesis181200;0,0001;0,0083;0,48;10,96;11,44;DIRC2;DIRC2;disrupted in renal carcinoma 2;cc;105113;0,0094;0,0099;0,42;10,48;10,90;DOCK5;DOCK5;dedicator of cytokinesis 5;;migration204989;0,0074;0,0095;0,36;10,96;11,32;DOK1;DOK1;"docking protein 1-like protein; docking protein 1, 62kDa (downstream of tyrosine kinase 1)";d, cc, i;neg regulator of insulin signaling. Tcell chemotaxis. Tumor suppressor. 219112;0,0085;0,0097;0,59;9,06;9,65;DPY19L2;DPY19L2;dpy-19-like 2 (C. elegans);;235719;0,0012;0,0083;0,48;10,43;10,91;EIF2C4;EIF2C4;eukaryotic translation initiation factor 2C, 4;;binds miRNAs214951;0,0057;0,0093;0,54;10,30;10,84;ELA3A;;;;203249;0,0064;0,0093;0,38;11,07;11,45;ENTPD1;ENTPD1;ectonucleoside triphosphate diphosphohydrolase 1;i;prevention of platelet aggregation. Thrombogenesis. (CD39). Modulated after execise. Loc at chol-rich domains. Neutrophil chemotaxis.113467;0,0007;0,0083;-0,52;15,60;15,08;EPB42;EPB42;erythrocyte membrane protein band 4.2;;erythrocyte shape205827;0,0084;0,0097;0,57;9,95;10,51;ERGIC1;ERGIC1;endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1;er;ER-golgi transport149090;0,0028;0,0092;0,33;14,31;14,64;ERICH1;ERICH1;glutamate-rich 1;;169478;0,0098;0,0100;-0,43;10,01;9,58;EXOC8;EXOC8;exocyst complex component 8;er;targeting of golgi-vesicles to plasma membrane. Cell migration, growt, polarity, cytoskeleton150137;0,0010;0,0083;0,61;10,01;10,62;FABP4;FABP4;fatty acid binding protein 4, adipocyte;fa, i, i, cvd;delivers FA to receptors in the nucleus. Interacts with PPARg. Upreg in obesity. Incr in endurance training. Loss of expr->bladder carcinoma. Polymorphisms assoc with cvd and diabetes. Eleated in metabolic syndrome. Serym levels pos. Assoc. With fat mass and weight, bmi,  waist circumf.102396;0,0035;0,0092;-0,37;15,36;14,99;FAM104A;FAM104A;family with sequence similarity 104, member A;;174755;0,0050;0,0092;0,27;13,17;13,44;FAM53C;FAM53C;family with sequence similarity 53, member C;;161432;0,0023;0,0092;-0,69;9,64;8,95;FAM63B;FAM63B;family with sequence similarity 63, member B;;121117;0,0048;0,0092;0,54;13,37;13,91;FCGRT;FCGRT;Fc fragment of IgG, receptor, transporter, alpha;i;binds albumine and IgG (important plasma proteins) and keeps them from degrad. Regulated by NFkB, calmodulin, IFNg, JAK/STAT. Antigen presenting.176815;0,0087;0,0097;-0,25;11,84;11,59;FEN1;FEN1;flap structure-specific endonuclease 1;cc;Interacts with PCNA. Base excision repair. Upreg in cancers.183378;0,0058;0,0093;0,30;10,27;10,58;FOLR2;FOLR2;folate receptor 2 (fetal);cc, fa;inc in malignant tissues. Upreg by retinoic acid186435;0,0048;0,0092;0,40;17,56;17,95;FPR1;FPR1;formyl peptide receptor 1;i;leukocyte migration, activation of neutrophils. Oxidant production? Cross talk with IgE receptor. Tumor promoting. Atherosclerosis174493;0,0053;0,0093;0,35;13,10;13,45;FPR2;FPR2;formyl peptide receptor 2;i;anti-finflam? Monocytes. Nfkb, decreased in asthma. Chemokine.209660;0,0038;0,0092;-0,31;11,53;11,23;FYTTD1;FYTTD1;forty-two-three domain containing 1;;110602;0,0070;0,0095;0,29;13,86;14,15;GALNAC4S-6ST;CHST15;carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15;i, s;B cell receptor157771;0,0039;0,0092;0,25;11,67;11,92;GBX2;GBX2;gastrulation brain homeobox 2;carc,;Expr assoc with cancer death.125012;0,0004;0,0083;-0,40;12,15;11,75;GCC2;GCC2;GRIP and coiled-coil domain containing 2;;endosome-golgi transport121984;0,0007;0,0083;-0,69;12,02;11,33;GFI1;GFI1;growth factor independent 1 transcription repressor;cc, i, ;proto-oncogene. Dvit. Hematopoiesis. Tcells. Normal development, tumorigenesis163121;0,0031;0,0092;0,44;10,46;10,90;GINS2;GINS2;GINS complex subunit 2 (Psf2 homolog);;DNA repl184881;0,0099;0,0100;0,32;12,02;12,34;GK;GK;"glycerol kinase 3 pseudogene; glycerol kinase";fa;mutation-hypertrigyceridemia. Glycerol uptake and metabolism185381;0,0013;0,0083;0,63;10,19;10,83;GLT1D1;GLT1D1;glycosyltransferase 1 domain containing 1;;180184;0,0046;0,0092;0,36;16,96;17,32;GMFG;GMFG;glia maturation factor, gamma;;hematopoiesis174153;0,0064;0,0093;-0,39;10,80;10,41;GOLT1A;GOLT1A;golgi transport 1 homolog A (S. cerevisiae);er;er-golgi vesicles fusion193676;0,0016;0,0083;0,32;12,16;12,48;GTF2I;GTF2I;general transcription factor II, i, pseudogene;i, er, cc;ER stress mediated induction of Grp78 (BIP!!!!). Activates cyclin D1. Blymph activation, required for Ig heavy chain transcription.170501;0,0009;0,0083;-0,34;15,96;15,62;GUK1;GUK1;guanylate kinase 1;;145583;0,0011;0,0083;-0,33;17,40;17,07;GYPC;GYPC;glycophorin C (Gerbich blood group);;red cell stability. Unfavourable outcome of childhood AL.149248;0,0011;0,0083;-0,36;15,02;14,66;HAGH;HAGH;hydroxyacylglutathione hydrolase;c, s;overexpr in some tumors181086;0,0033;0,0092;0,40;11,78;12,18;HAL;HAL;histidine ammonia-lyase;;Retinoic acid modulates expr. Expr initiated via PKC and PKA.209485;0,0074;0,0095;0,16;14,73;14,89;HCV F-transactivated protein 1;;;;194873;0,0005;0,0083;1,41;9,78;11,19;HDC;HDC;histidine decarboxylase;c;Increased in tumor. Angiogenesis in esophageal cancer.170038;0,0045;0,0092;0,25;14,65;14,90;HEBP2;HEBP2;heme binding protein 2;;heme-binding. Necrosis206232;0,0083;0,0097;0,43;13,23;13,66;HIST1H1C;HIST1H1C;histone cluster 1, H1c;;p53…184281;0,0044;0,0092;0,32;12,23;12,55;HIST1H2AD;HIST1H2AD;"histone cluster 1, H3j; histone cluster 1, H3i; histone cluster 1, H3h; histone cluster 1, H3g; histone cluster 1, H3f; histone cluster 1, H3e; histone cluster 1, H3d; histone cluster 1, H3c; histone cluster 1, H3b; histone cluster 1, H3a; histone cluster 1, H2ad; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3d";c;tumorigenesis..138287;0,0031;0,0092;0,34;12,51;12,85;HIST1H2BJ;HIST1H2BJ;histone cluster 1, H2bj;i, c;nucleosome. Antibacterial activity193947;0,0013;0,0083;0,30;12,60;12,90;HIST1H2BM;HIST1H2BM;histone cluster 1, H2bm;i, c;nucleosome. 149647;0,0071;0,0095;0,32;15,73;16,04;HIST2H2AA3;HIST2H2AA3;"histone cluster 2, H2aa3; histone cluster 2, H2aa4";;nucl127609;0,0079;0,0097;0,32;14,44;14,75;HIST3H3;HIST3H3;histone cluster 3, H3;;telomerase regulation. Decreased expr during cell differentiation156653;0,0047;0,0092;-0,43;11,77;11,34;HNRNPL;HNRNPL;"similar to heterogeneous nuclear ribonucleoprotein L-like; heterogeneous nuclear ribonucleoprotein L";;pre-mRNA processing220847;0,0041;0,0092;0,49;9,68;10,17;HOXC12;HOXC12;homeobox C12;;226440;0,0005;0,0083;-0,30;10,96;10,65;hypothetical protein;;;;112888;0,0088;0,0097;-0,75;11,57;10,82;IFIT1L;IFIT1B;interferon-induced protein with tetratricopeptide repeats 1B;i;interferon induced195577;0,0007;0,0083;0,52;17,56;18,08;IFITM3;IFITM3;interferon induced transmembrane protein 3 (1-8U);c, i;colon cancer development200014;0,0015;0,0083;0,36;13,35;13,72;IL10RB;IL10RB;interleukin 10 receptor, beta;i;receptor for il10 and il22, and IFNlambda. SLE! Systemic sclerosis.186009;0,0034;0,0092;0,44;14,94;15,39;IL1R2;IL1R2;interleukin 1 receptor, type II;i, c;Receptor for il1A, il1B and il-1ra. Binding of IL1 causes reduction in IL1 signaling: Il1-scavenger. Endometriosis. Enhance cell migration. Higher levels in ovarian cancer.104745;0,0014;0,0083;-0,42;10,84;10,42;INPP4B;INPP4B;inositol polyphosphate-4-phosphatase, type II, 105kDa;;Phosphatidylinositol sign pathway139346;0,0065;0,0093;0,46;12,38;12,84;ISL2;ISL2;ISL LIM homeobox 2;;216566;0,0049;0,0092;-0,45;11,30;10,85;ITPR3;ITPR3;inositol 1,4,5-triphosphate receptor, type 3;ca, d;Ca channel. Releas of CA2+ upon I3P binding. Gastric cancer. SNPs imoprtant to diabetes in Sweden! SLE! Huntingtons.157046;0,0080;0,0097;-0,35;11,24;10,90;karyopherin alpha-2 subunit like;;;;135422;0,0064;0,0093;0,39;9,85;10,25;KCNU1;KCNU1;potassium channel, subfamily U, member 1;;158049;0,0030;0,0092;-0,47;10,55;10,08;KIAA0564;KIAA0564;KIAA0564;;113852;0,0096;0,0100;-0,37;11,40;11,03;KIAA0831;KIAA0831;KIAA0831;autoph;Positively controls autophagy through Beclin-1. Synonym: Barkor188801;0,0023;0,0092;-0,58;13,47;12,89;KLRG1;KLRG1;killer cell lectin-like receptor subfamily G, member 1;i;Inhibits NK ant T cell function. Binds E-cadherin122027;0,0003;0,0083;-0,35;12,20;11,85;LANCL1;LANCL1;LanC lantibiotic synthetase component C-like 1 (bacterial);;192802;0,0042;0,0092;-0,39;15,67;15,27;LBH;LBH;limb bud and heart development homolog (mouse);;192374;0,0098;0,0100;-0,26;11,90;11,64;LRPPRC;LRPPRC;leucine-rich PPR-motif containing;i, fa;cytoskeleton, vesucular trafficing. Transcription, chrom remodeling. Interacts with PPARgc1a. Defects in gene is cause of Leigh syndrome (…), and assoc with systemic COX deficiency212496;0,0019;0,0088;-0,29;14,43;14,14;MAF1;MAF1;MAF1 homolog (S. cerevisiae);;represses RNApol transcription.187717;0,0019;0,0088;-0,35;10,04;9,69;MAGT1;MAGT1;magnesium transporter 1;;213342;0,0087;0,0097;0,46;12,36;12,81;MANSC1;MANSC1;MANSC domain containing 1;;10715781;0,0052;0,0093;-0,45;10,00;9,55;MAP6;MAP6;microtubule-associated protein 6;;schizo. Calmodulin229698;0,0019;0,0088;-0,66;10,10;9,45;MATR3;MATR3;matrin 3;;calmodulin. Transcription209973;0,0016;0,0083;-0,33;11,40;11,07;MCM3;MCM3;minichromosome maintenance complex component 3;cc;DNA repl. Cell prolif. Elevated levels assoc with neoplasms.197624;0,0015;0,0083;0,40;12,06;12,46;METRNL;METRNL;"meteorin, glial cell differentiation regulator-like; similar to meteorin, glial cell differentiation regulator-like";;188640;0,0023;0,0092;-0,70;10,29;9,60;MINPP1;MINPP1;multiple inositol polyphosphate histidine phosphatase, 1;c;thyroid tumor. Regulates cellular levels of InsP5 and 6.227814;0,0053;0,0093;-0,39;15,38;14,99;MKRN1;MKRN1;"makorin ring finger protein pseudogene 6; makorin ring finger protein 1";;transcription163166;0,0052;0,0093;0,37;11,81;12,18;MLF2;MLF2;myeloid leukemia factor 2;;195045;0,0026;0,0092;0,41;9,76;10,17;MLL;MLL;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);cc, c;leukemia. Oncogene. Myeloid malignancies. Fusions with others.122196;0,0090;0,0097;-0,18;11,78;11,60;MRPS35;MRPS35;mitochondrial ribosomal protein S35;;182643;0,0013;0,0083;1,00;9,79;10,79;MS4A2;MS4A2;"membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide)";i;FcER1B! Initiates allergic response. Induces cecretion of lymphokines. Rsik factor for asthma and atopy.112249;0,0035;0,0092;-0,48;10,45;9,97;MTR;MTR;5-methyltetrahydrofolate-homocysteine methyltransferase;cvd;Mild deficiency assoc with CVD.207803;0,0036;0,0092;-0,63;11,43;10,80;MYBL1;MYBL1;v-myb myeloblastosis viral oncogene homolog (avian)-like 1;;transcriptional activator. Expressed in turmor cell lines.201601;0,0014;0,0083;1,18;9,39;10,57;MYBPHL;MYBPHL;myosin binding protein H-like;;171663;0,0032;0,0092;-0,46;14,84;14,37;MYL4;MYL4;"myosin, light chain 4, alkali; atrial, embryonic";;176322;0,0023;0,0092;0,25;13,09;13,34;NBPF10;NBPF10;"neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8";c;Candidate amplified oncogene116214;0,0075;0,0096;-0,42;13,49;13,07;NELL2;NELL2;NEL-like 2 (chicken);;Binds PKC234890;0,0072;0,0095;-0,51;17,66;17,15;NEUROG2;NEUROG2;neurogenin 2;;203863;0,0073;0,0095;0,31;13,59;13,90;NFIL3;NFIL3;nuclear factor, interleukin 3 regulated;;transcriptional repressor180149;0,0047;0,0092;-0,28;13,06;12,78;NLGN2;NLGN2;neuroligin 2;;125296;0,0047;0,0092;0,55;9,13;9,68;NPFFR1;NPFFR1;neuropeptide FF receptor 1;;receptor for morphine-modulating peptides211955;0,0008;0,0083;-0,59;10,66;10,08;NR2C2AP;NR2C2AP;nuclear receptor 2C2-associated protein;;apoptosis, differentiation. Retinoic acid.124033;0,0039;0,0092;0,27;11,48;11,74;NT5C2;NT5C2;5'-nucleotidase, cytosolic II;c?;myelodysplastic syndrome. 169345;0,0097;0,0100;-0,25;11,77;11,52;NUDCD3;NUDCD3;NudC domain containing 3;;129441;0,0010;0,0083;-0,35;15,96;15,60;OPTN;OPTN;optineurin;i, er;FIP2. Golci, trafficing, exocytosis. TNFa signaling pathway, NFkB, induction of cell death.702434;3.5e-05;0,0083;-0,70;11,78;11,09;OR2W3;OR2W3;"olfactory receptor, family 2, subfamily T, member 8; olfactory receptor, family 2, subfamily W, member 3";;Little info171625;0,0021;0,0092;0,37;12,72;13,09;PGM2;PGM2;phosphoglucomutase 2;d?;Breakdown and synthesis of glucose195337;0,0054;0,0093;-0,36;14,28;13,91;PIP4K2A;PIP4K2A;phosphatidylinositol-5-phosphate 4-kinase, type II, alpha;;platelet function. Schizo208060;0,0018;0,0087;0,36;12,95;13,32;PLAUR;PLAUR;plasminogen activator, urokinase receptor;i, CVD, c;receptor for urokinase plasminogen activator. Tumor marker. Hypoxia. Kallikrein.Upreg by IL-1a. Invasive behaviour. MeK/Erk sign. Caveolin. EGFinduced. Cell migration, metastasis etc. Macrophages, plaque rupture, atheroscl.!102211;0,0085;0,0097;-0,50;9,98;9,49;PMS1;PMS1;PMS1 postmeiotic segregation increased 1 (S. cerevisiae);c;gene defect causes hereditary non-polyposis colorectal cancer. DNA repair. Reduced expression in some lymphomas. 153575;0,0070;0,0095;-0,28;11,98;11,70;PPP3CC;PPP3CC;protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform;ca;calcium, calmodulin, Susceptibility gene for schizo.129668;0,0100;0,0100;0,28;11,91;12,19;PPP4R1;PPP4R1;protein phosphatase 4, regulatory subunit 1;;cell division…167444;0,0091;0,0097;0,60;9,21;9,81;PRR4;PRR4;proline rich 4 (lacrimal);;112567;0,0078;0,0097;0,53;13,74;14,27;PTAFR;PTAFR;platelet-activating factor receptor;i, c, cvd;Receptor for PAF! Epithel cell function. LDL, inflam, Bcell lymphoma, atheroscl plaque formation. Regulation of COX-II, PGE(2), IL-8. 128131;0,0052;0,0093;-0,30;12,90;12,60;PTPN7;PTPN7;protein tyrosine phosphatase, non-receptor type 7;;T and B cell development. Acts on MAPK1. 138013;0,0089;0,0097;-0,33;12,28;11,95;PYROXD1;PYROXD1;pyridine nucleotide-disulphide oxidoreductase domain 1;;190571;0,0058;0,0093;0,30;14,27;14,57;RAB2A;RAB2A;RAB2A, member RAS oncogene family;er, d;required for protein transport from er to golgi. Interacts with atypical PKCiota/lambda. Regulates early transport of secretory insuline secretory granule proteins. 191530;0,0082;0,0097;0,26;13,36;13,62;RALB;RALB;"v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)";c, ca;binds calmodulin. Survival of tumor cells. Metastasis129740;0,0013;0,0083;0,50;13,16;13,66;RBP7;RBP7;retinol binding protein 7, cellular;;intracell transport of retinol178139;0,0037;0,0092;0,38;13,34;13,72;RGS19;RGS19;regulator of G-protein signaling 19;;transcription116793;0,0002;0,0083;0,60;14,18;14,78;RGS2;RGS2;regulator of G-protein signaling 2, 24kDa;c, cvd, ca;Inhibits sign transd. Phosphorylated by PKC. Leukemia. Myeloid differentiation. Androgen receptor signaling. Hypertension. Ca2+ channel inhibitor. Suicide, anxiety, schizo. Modulates oxytocin receptor signaling. Overexpressed in breast cancer. Incerased expression-low blood pressure. 158499;0,0092;0,0098;-0,25;11,07;10,81;RIBC2;RIBC2;RIB43A domain with coiled-coils 2;;110449;0,0056;0,0093;0,44;10,04;10,48;ROPN1B;ROPN1B;ropporin, rhophilin associated protein 1B;;183687;0,0041;0,0092;0,54;10,86;11,40;ROPN1L;ROPN1L;ropporin 1-like;;112476;0,0084;0,0097;0,50;9,20;9,70;RRAGD;RRAGD;Ras-related GTP binding D;;162558;0,0069;0,0095;-0,32;11,37;11,04;RRM1;RRM1;ribonucleotide reductase M1;cc, c;Provides precursors for DNA synthesis. Cancer. Chemotherapy marker. Metastasis suppressor through PTEN.164104;0,0065;0,0093;0,28;15,11;15,38;RXRA;RXRA;retinoid X receptor, alpha;Fa, c, cvd. ;Nuclear hormone receptor. Fatty acids, VitD. IL-3.Binds PPARb and PPARg. Binds oxPhospholipids and inhibits transcription of thrombomodulin.Tumor development. Fatty acid receptor? Induces transcr of Angptl3. Activation is anti-atherogen. Ligand-binding may inhibit high-glucose-induced ox stress.145550;0,0087;0,0097;0,28;19,01;19,29;S100A11;S100A11;"S100 calcium binding protein A11; S100 calcium binding protein A11 pseudogene";c, cc, Ca, i;Differentiation of keratinocytes. Tumor marker:decreased expr. Mediates Ca2+induced growth inhibition via PKCa and TGFb. Up-reg assoc with metastasis. Anti-apoptotic. Donw-reg poor prognosis. Inhibits cPLA2. p21. Inflam and arthritis. 154326;0,0034;0,0092;0,31;17,73;18,04;S100A6;S100A6;S100 calcium binding protein A6;c, cc, Ca, i;Proliferation, overexpr in leukemias. Ca2+. Activated by NFkB/TNFa. Regulates Hsp70 and Hsp90. Casp3. Limit post-infarction apoptosis of cardiomyocytes. P53. 214501;0,0044;0,0092;0,52;10,04;10,56;S100Z;S100Z;S100 calcium binding protein Z;ca;165679;0,0047;0,0092;-0,40;11,64;11,24;SAMD3;SAMD3;sterile alpha motif domain containing 3;;213781;0,0069;0,0095;0,36;11,40;11,76;SDF4;SDF4;stromal cell derived factor 4;ca, er;Regulates Ca-dependent activities in the ER or post-ER compartment.146482;0,0064;0,0093;0,57;10,26;10,83;SH2B2;SH2B2;SH2B adaptor protein 2;d, i;neg regl of insulin signaling and/or Jak2 mediated processes. Immunoreceptor sign. Regulated by cytokines. Expressed in B cells. 147339;0,0045;0,0092;-0,43;10,68;10,25;SHQ1;SHQ1;SHQ1 homolog (S. cerevisiae);;220354;0,0059;0,0093;-0,34;12,25;11,90;similar to hypothetical protein MGC49416 (EC:3.-.-.-);;;;165607;0,0087;0,0097;0,26;14,31;14,57;SLC11A1;SLC11A1;solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1;i, d, c;iron metabolism. diabetes onset, tuberculosis, inflam bowel disease.Chron's. Infections, autoimmunity and cancer. Regulated by HIF-1.149707;0,0029;0,0092;0,36;13,69;14,05;SLC19A1;SLC19A1;solute carrier family 19 (folate transporter), member 1;cc;Anti-folate treatment like methotrexate. Reg by Sp-1 and c/ebpb. Pharmacologically important transport system. 206544;0,0014;0,0083;0,62;9,67;10,29;SLC22A9;SLC22A9;solute carrier family 22 (organic anion transporter), member 9;;Neg regulated by progesterone and PKC. Uptake of steroide sulphates.219146;0,0081;0,0097;-0,29;11,53;11,23;SLC6A18;SLC6A18;solute carrier family 6, member 18;;170285;0,0091;0,0097;-0,63;16,90;16,27;SNCA;SNCA;synuclein, alpha (non A4 component of amyloid precursor);i, fa;Interacts with Fatty acids to promote protein aggr. dementia, parkinsons. Leads to decreased casp3 activation: anti-apoptotic. Regulated by inflammatory signals. Clatrin. Vesicle trafficing. Stimulates expr of IL-6 and ICAM-1. Neuronal function.181922;0,0034;0,0092;-0,57;10,48;9,91;SNX15;SNX15;sorting nexin 15;er;intracell protein trafficing189841;0,0090;0,0097;-0,22;12,18;11,96;SPATA22;SPATA22;spermatogenesis associated 22;;221741;0,0040;0,0092;-0,45;9,69;9,24;SPECC1;;;;174543;0,0041;0,0092;-0,41;10,28;9,87;SPSB1;SPSB1;splA/ryanodine receptor domain and SOCS box containing 1;;Ubiquitination133333;0,0098;0,0100;0,25;17,96;18,20;SRGN;SRGN;serglycin;i, cc,;formation of mast cell secretory granules, storage in vesicles. Storage of granzymeB i Tcells (induces apoptosis). Regulages TNFa secr. Regulated by chromatin remod.142288;0,0098;0,0100;-0,37;11,76;11,39;SRRD;SRRD;SRR1 domain containing;;123115;0,0092;0,0098;-0,32;12,71;12,39;ST6GALNAC4;ST6GALNAC4;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4;Gly;158699;0,0015;0,0083;-0,35;14,62;14,26;STAT4;STAT4;signal transducer and activator of transcription 4;d, i, ;Essential for IL-12 sign. Type 1 diabetes, Rheumatoid arthr, SLE, Chron's, Sjøgrens. Signaling activated by IFNa, cytokines, NFkB. 116303;0,0038;0,0092;0,33;14,22;14,55;SULF2;SULF2;sulfatase 2;Ca, i, ;Ca binding. Growth inhibitor. Arthritis. Heparin. Angiogenesis. Regulate the activities of multiple growth facors like Wnt and FibroblastGF. P53.212648;0,0061;0,0093;-0,54;10,02;9,48;TADA1L;;;;155101;0,0049;0,0092;0,51;9,36;9,88;TBC1D30;TBC1D30;TBC1 domain family, member 30;;132590;0,0034;0,0092;1,20;9,23;10,43;TCHHL1;TCHHL1;trichohyalin-like 1;;184655;0,0016;0,0083;0,37;12,04;12,41;TLR8;TLR8;toll-like receptor 8;i;Leads to NFkB activation, cytokine secretion and inflam response. Activated by bacteria and virus. Asthma, RA, 105353;0,0072;0,0095;0,57;9,95;10,52;TMC4;TMC4;transmembrane channel-like 4;;138581;0,0035;0,0092;-0,37;11,78;11,42;TMCC2;TMCC2;transmembrane and coiled-coil domain family 2;;143933;0,0025;0,0092;0,46;11,44;11,89;TMCC3;TMCC3;transmembrane and coiled-coil domain family 3;;206786;0,0081;0,0097;0,37;11,75;12,12;TMEM120A;TMEM120A;transmembrane protein 120A;;202078;0,0091;0,0097;-0,47;13,87;13,41;TMEM123;TMEM123;transmembrane protein 123;;implicated in oncotic cell death. Passive cell death due to failure of plama membranes ionic pump.132060;0,0010;0,0083;0,27;12,95;13,22;TMEM127;TMEM127;transmembrane protein 127;;205179;0,0005;0,0083;-0,30;11,43;11,12;TMEM138;TMEM138;transmembrane protein 138;;182763;0,0062;0,0093;-0,31;10,75;10,44;TMEM62;TMEM62;transmembrane protein 62;;104200;0,0037;0,0092;-0,22;11,66;11,44;TRAPPC2;TRAPPC2;"trafficking protein particle complex 2; trafficking protein particle complex 2 pseudogene 1";;Vesicular transport. Bone.154230;0,0079;0,0097;0,40;14,62;15,02;TREM1;TREM1;triggering receptor expressed on myeloid cells 1;i;Stimulates inflammatory responses. Triggers release of cytokines and chemokines. Upreg by bacteria, fungi and LPS. Systemic inflam response. Inflam bowel disease. Regulated by PGE2! Can be increased without infection. NFkB. Increased in COPD (Kols)236837;0,0049;0,0092;0,30;13,00;13,31;TRIM17;TRIM17;tripartite motif-containing 17;;394995;0,0087;0,0097;-0,31;11,44;11,13;TRPV3;TRPV3;transient receptor potential cation channel, subfamily V, member 3;ca;Ca channel. 152777;0,0060;0,0093;0,29;15,12;15,41;TSEN34;TSEN34;tRNA splicing endonuclease 34 homolog (S. cerevisiae);;mRNA and tRNA processing. 178683;0,0094;0,0099;-0,45;12,53;12,08;TUBG1;TUBG1;"tubulin, gamma 1; similar to Tubulin, gamma 1";;179329;0,0007;0,0083;0,37;17,63;18,00;TYROBP;TYROBP;TYRO protein tyrosine kinase binding protein;i;regulate NK cells. Expressed in hematological cells. 208303;0,0099;0,0100;-0,53;10,01;9,48;UBE2T;UBE2T;ubiquitin-conjugating enzyme E2T (putative);c;upreg in lungcancer332119;0,0037;0,0092;-0,39;13,77;13,39;UHMK1;UHMK1;U2AF homology motif (UHM) kinase 1;cc;G1 progression. Induced by serum growth factors. Schizo. Overwxpr in leukemias. 109540;0,0068;0,0095;0,43;10,81;11,24;UHRF1BP1L;UHRF1BP1L;UHRF1 binding protein 1-like;;149070;0,0007;0,0083;0,52;13,14;13,66;UTF1;UTF1;undifferentiated embryonic cell transcription factor 1;;130288;0,0010;0,0083;-0,47;10,95;10,48;WDR7;WDR7;WD repeat domain 7;;202070;0,0030;0,0092;-0,30;11,11;10,81;ZC3HC1;ZC3HC1;zinc finger, C3HC-type containing 1;cc;controls mitotic entry by mediating ubi and degrad of cyclin B1. anti-apoptotic. 182917;0,0082;0,0097;-0,42;9,76;9,34;ZFYVE1;ZFYVE1;zinc finger, FYVE domain containing 1;;binds posphIns3P108930;0,0053;0,0093;0,34;9,47;9,81;ZNF169;ZNF169;zinc finger protein 169;;transcriptional regulation221425;0,0080;0,0097;0,40;9,23;9,63;ZNF434;ZNF434;zinc finger protein 434;;transcriptional regulation124882;0,0003;0,0083;0,63;10,07;10,70;ZNF558;ZNF558;zinc finger protein 558;;transcriptional regulation219763;0,0045;0,0092;-0,28;10,56;10,27;ZNF564;ZNF564;zinc finger protein 564;;transcriptional regulation200021;0,0017;0,0086;-0,28;11,86;11,57;ZNF766;ZNF766;zinc finger protein 766;;transcriptional regulation124354;0,0073;0,0095;-0,28;13,91;13,63;ZNF91;ZNF91;zinc finger protein 91;;